MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 62 filers reported holding MARRONE BIO INNOVATIONS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,000 | -25.0% | 7,972 | -27.4% | 0.00% | – |
| Q1 2022 | $12,000 | +50.0% | 10,982 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -20.0% | 10,982 | 0.0% | 0.00% | – |
| Q3 2021 | $10,000 | -44.4% | 10,982 | 0.0% | 0.00% | – |
| Q2 2021 | $18,000 | +12.5% | 10,982 | +46.7% | 0.00% | – |
| Q1 2021 | $16,000 | +77.8% | 7,487 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | 0.0% | 7,487 | 0.0% | 0.00% | – |
| Q3 2020 | $9,000 | -25.0% | 7,487 | -25.5% | 0.00% | – |
| Q2 2020 | $12,000 | +50.0% | 10,051 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | -20.0% | 10,051 | 0.0% | 0.00% | – |
| Q4 2019 | $10,000 | -9.1% | 10,051 | +23.6% | 0.00% | – |
| Q3 2019 | $11,000 | -8.3% | 8,134 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | 0.0% | 8,134 | 0.0% | 0.00% | – |
| Q1 2019 | $12,000 | 0.0% | 8,134 | 0.0% | 0.00% | – |
| Q4 2018 | $12,000 | -20.0% | 8,134 | 0.0% | 0.00% | – |
| Q3 2018 | $15,000 | 0.0% | 8,134 | 0.0% | 0.00% | – |
| Q2 2018 | $15,000 | – | 8,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 18,335,767 | $21,269,000 | 3.50% |
| OAK FAMILY ADVISORS, LLC | 895,873 | $1,039,000 | 0.52% |
| Shay Capital LLC | 2,145,580 | $2,489,000 | 0.50% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 2,002,214 | $2,323,000 | 0.47% |
| EHP Funds Inc. | 956,381 | $1,109,000 | 0.18% |
| Alpine Global Management, LLC | 524,318 | $608,000 | 0.15% |
| Ergoteles LLC | 1,360,987 | $1,579,000 | 0.05% |
| Clear Harbor Asset Management, LLC | 243,671 | $283,000 | 0.04% |
| Diametric Capital, LP | 22,590 | $26,000 | 0.02% |
| FNY Investment Advisers, LLC | 20,000 | $23,000 | 0.02% |